AI assistant
BioVaxys Technology Corp. — Board/Management Information 2021
Feb 8, 2021
47641_rns_2021-02-08_c12b0c50-1b6a-4f9b-a4c2-1da2cf3ed8dc.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [338 x 55] intentionally omitted <==
BioVaxys Announces Director Change
VANCOUVER, BC ― February 8, 2021 ― BioVaxys Technology Corp. CSE: BIOV; (“ BioVaxys ” or the “ Company ”), announces that Jeremy Poirier, a director of the Company, has resigned to pursue other endeavors.
"Mr. Poirier was a founding director and instrumental in assisting the Company to complete its acquisition of BioVaxys Inc. We would like to sincerely thank him for his assistance and wish will in his future endeavors," says James Passin, Chief Executive Officer of the Company.
ON BEHALF OF THE BOARD
Signed "James Passin" James Passin, CEO +1 646 452 7054 [email protected]
Media Contacts Andrea Vuturo +1 508 301 3774 [email protected]